| Literature DB >> 26213542 |
Saeed Moradi1, Nasrollah Saghravanian2, Siavash Moushekhian1, Samar Fatemi3, Maryam Forghani4.
Abstract
INTRODUCTION: The aim of the present study was to evaluate the expression of fibronectin (FN) and tenascin (TN) after direct pulp capping (DPC) in dogs' teeth with either mineral trioxide aggregate (MTA), Propolis or Platelet-rich plasma (PRP), by means of immunohistochemistry. METHODS AND MATERIALS: A total of 48 sound molars and premolars with mature apices from four dogs, were included. The teeth were randomly divided into 4 groups according to the material used for DPC: PRP, Propolis, MTA, and glass-ionomer (as the negative control group). Each group was divided into two 7-day and 30-day subgroups. The teeth were restored at the same session. The animals were sacrificed at the mentioned time intervals and the expression of FN and TN in each test group and between each time intervals was assessed with Wilcoxon and Mann-Whitney U tests, respectively. The Kruskal-Wallis test was used to compare FN and TN staining among the test groups. The significance level was set at 0.05.Entities:
Keywords: Fibronectin; Immunohistochemistry; Propolis; Pulp Capping; Tenascin
Year: 2015 PMID: 26213542 PMCID: PMC4509128 DOI: 10.7508/iej.2015.03.009
Source DB: PubMed Journal: Iran Endod J ISSN: 1735-7497
Figure 1A) Expression of FN (grade III) in the PRP group after 7 days (100× magnification), B) Expression of FN (grade II) in the Propolis group after 7 days (100× magnification), C) Expression of FN (grade I) in the MTA sample after 7 days (100× magnification), D) Expression of TN (grade II) in the PRP group after 30 days(×100 magnification), E) Expression of TN (grade II) in the Propolis group after 30 days (100× magnification) and F) Expression of TN (grade IV) in the MTA group after 30 days (400× magnification
Summary of FN Expression after 7 and 30 days [N (%)]
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|
| Group I | Group II | Group III | Group IV | Group I | Group II | Group III | Group IV | |
|
| 0 (0%) | 2 (33.3%) | 4 (66.6%) | 0 (0%) | 0 (0%) | 3 (50%) | 3 (50%) | 0 (0%) |
|
| 1 (16.6%) | 2 (33.3%) | 3 (50%) | 0 (0%) | 0 (0%) | 0 (0%) | 5 (83.3%) | 1 (16.6%) |
|
| 0 (0%) | 3 (50%) | 3 (50%) | 0 (0%) | 0 (0%) | 0 (0%) | 4 (66.6%) | 2 (33.3%) |
|
| 0 (0%) | 3 (50%) | 2 (33.3% | 1 (16.6%) | 2 (33.3%) | 3 (50%) | 1 (16.6%) | 0 (0%) |
Summary of TN Expression after 7 and 30 days [N (%)]
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|
| Group I | Group II | Group III | Group IV | Group I | Group II | Group III | Group IV | |
|
| 0 (0%) | 2 (33.3%) | 4 (66.6%) | 0 (0%) | 0 (0%) | 3 (50%) | 3 (50%) | 0 (0%) |
|
| 1 (16.6%) | 2 (33.3%) | 3 (50%) | 0 (0%) | 0 (0%) | 0 (0%) | 5 (83.3%) | 1 (16.6%) |
|
| 0 (0%) | 3 (50%) | 3 (50%) | 0 (0%) | 0 (0%) | 0 (0%) | 4 (66.6%) | 2 (33.3%) |
|
| 0 (0%) | 3 (50%) | 2 (33.3% | 1 (16.6%) | 2 (33.3%) | 3 (50%) | 1 (16.6%) | 0 (0%) |